NCT06659263View on ClinicalTrials.gov

RE104 Clinical Lactation Study

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

May 28, 2025

Study Completion Date

June 4, 2025

Conditions
Lactation
Interventions
DRUG

RE104 for Injection

Single, subcutaneous dose of RE104 for Injection

Trial Locations (1)

89113

PPD Inc, Las Vegas

All Listed Sponsors
lead

Reunion Neuroscience Inc

INDUSTRY

NCT06659263 - RE104 Clinical Lactation Study | Biotech Hunter | Biotech Hunter